Three analysts set bullish Anthropic targets ahead of its $83-a-share debut
The recommendations rest on enterprise AI spending, rapid revenue growth and management continuity. They are forecasts, not opening-day trading results.
Loading page…
The recommendations rest on enterprise AI spending, rapid revenue growth and management continuity. They are forecasts, not opening-day trading results.
Listen to this story
The investment case rests on Claude moving from trials into core enterprise workflows: Melius says Anthropic is best positioned to monetize AI, while Wolfe argues it could add more revenue in 2028 than any other company. Targets from Citizens, Wolfe and Melius range from $125 to $155 against the $83 IPO price, but they are forecasts, not realized returns or assurances about opening-day trading. Citizens’ revenue projections show the scale of the bet; the offering is mostly shares sold by Anthropic and is expected to close after Nasdaq trading begins.
Citizens set a $125 target, Wolfe Research $135 and Melius Research $155, implying roughly 51%, 63% and 87% upside from $83, respectively.
Citizens forecasts revenue of $52.5 billion in 2026, $137 billion in 2027 and $417.8 billion in 2029; these are estimates, not reported results.
Anthropic is selling 956,351,354 of the 980 million base shares; existing holders are selling 23,648,646 and receive no proceeds from Anthropic’s share sale.
Anthropic has three bullish stock recommendations before its scheduled Nasdaq debut on November 19, 2026. Wolfe Research, Citizens and Melius Research have set price targets of $125–$155, CNBC reported, against an $83 initial public offering price. Their forecasts put enterprise AI spending and extraordinary revenue expectations at the center of the investment case.
Anthropic confirmed the $83 price in its November 18 offering announcement. That is above the previously expected $70–$78 range. Shares are expected to trade on the Nasdaq Global Select Market under ANT; the announcement sets out the offering terms, not a public-market trading price.
The three firms initiated coverage with different labels but the same favorable direction: outperform at Wolfe, market outperform at Citizens and buy at Melius. CNBC calculated their potential gains against the IPO price. Those percentages describe the distance to each analyst’s target, not returns investors have already earned or promises about the first trading session.
Market outperform rating; the target implies about 51% upside from the $83 offering price, according to CNBC.
Outperform rating; the target implies nearly 63% upside from the offering price, according to CNBC.
Buy rating; the target implies about 87% upside from the offering price, according to CNBC.
Melius analyst Ben Reitzes called Anthropic the company best positioned to make money from AI. His argument centers on customers moving beyond experiments and putting Claude deeper into their core business processes. In his view, that shift would allow Anthropic to capture a growing share of enterprise spending as AI changes productivity, innovation and knowledge work.
Wolfe analyst Alex Zukin emphasized the scale of the potential market and Anthropic’s growth. In a Thursday client note, he argued that the company has a path to add more revenue in calendar 2028 than any other business. That is a central part of Wolfe’s bullish thesis, rather than an outcome Anthropic has delivered.
Citizens analyst Patrick Walravens highlighted management continuity: all seven co-founders remain at Anthropic nearly six years after its founding, he wrote. He also credited its technical founders with advances behind modern AI. His case therefore includes the people running the company, alongside the size of the commercial opportunity.
Citizens puts numbers on that opportunity. It forecasts $52.5 billion in revenue for 2026, more than 1,000% above the previous year. It then projects $137.0 billion for 2027 and $417.8 billion for 2029. These are Citizens’ estimates, not reported annual results or revenue commitments from customers.
The offering consists of 980 million Class A shares. Anthropic is selling 956,351,354 of them, while existing stockholders are selling 23,648,646. The company will receive no proceeds from those stockholders’ sales. That allocation makes the transaction primarily a sale of shares by Anthropic itself, rather than an exit for existing holders.
Anthropic has also given the underwriters—the banks handling the offering—a 30-day option to purchase up to 147 million additional shares. That is an option beyond the announced base offering, not a statement that those extra shares have already been purchased. The SEC declared the registration statement effective on November 18.
The offering is expected to close on November 20, subject to customary conditions. That closing is separate from the scheduled November 19 start of Nasdaq trading.
Loading discussion...
Join the conversation
Explain what founder continuity does—or doesn’t—tell you.
Be the first to share a perspective or an experience.
Reader comments
Newest comments first. Replies stay oldest first.